REHABILITATION INSTITUTE OF CHICAGO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1954-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ric.org/
NervGen Pharma to Present Phase 1b/2a Trial of NVG-291 for Spinal Cord Injury at Upcoming Investor Event
NervGen Pharma will host a virtual investor event on April 9, 2025, featuring key opinion leaders to discuss the unmet medical needs and treatment landscape for spinal cord injury patients.